| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/27/2005 | US20050019417 stabilization of proteins, peptides or cells by fluidization of microparticles to form fluidized bed of microparticles comprising water soluble gel forming solid particles, then spraying coating with liquids comprising sugars and solvents, and drying |
| 01/27/2005 | US20050019389 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 01/27/2005 | US20050019378 Transdermal drug delivery system of strychnine, brucine, securinine and their salts |
| 01/27/2005 | US20050019375 Consumable farinaceous food comprising alpha -cyclodextrin and fat having same amounts of calories and cholesterol; reduced bioavailability, increased high density lipoproteins |
| 01/27/2005 | US20050019347 Dna sequences and coding for hepatitis virus antigen |
| 01/27/2005 | US20050019274 Biofilm removing agent for removing a biofilm |
| 01/27/2005 | CA2805464A1 Human antibody molecules for il-13 |
| 01/27/2005 | CA2804901A1 Human antibody molecules for il-13 |
| 01/27/2005 | CA2531817A1 Kappa agonists, especially for the treatment and/or prophylaxis of irritable bowel syndrome |
| 01/27/2005 | CA2531343A1 Enema preparation |
| 01/27/2005 | CA2529790A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 01/26/2005 | EP1500658A1 Novel thiol derivative, process for producing the same and use thereof |
| 01/26/2005 | EP1500657A1 Substituted pyrazoles as P38 kinase inhibitors |
| 01/26/2005 | EP1500654A1 Benzoxazinone derivatives, the preparation and use thereof as medicaments |
| 01/26/2005 | EP1500643A1 Benzamide derivatives |
| 01/26/2005 | EP1500402A1 Cell death inhibitor |
| 01/26/2005 | EP1500397A1 Adsorbents for oral administration, remedies or preventives for kidney diseases and remedies or preventives for liver diseases |
| 01/26/2005 | EP1500389A1 Biofilm removing agent |
| 01/26/2005 | EP1499746A1 Method to inhibit cell growth using oligonucleotides |
| 01/26/2005 | EP1499729A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 01/26/2005 | EP1499724A1 Derivatives of the il-2 receptor gamma chain, their production and use |
| 01/26/2005 | EP1499721A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription factors |
| 01/26/2005 | EP1499623A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one |
| 01/26/2005 | EP1499619A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof |
| 01/26/2005 | EP1499618A1 Furyl compounds |
| 01/26/2005 | EP1499616A1 Heterocyclic compounds |
| 01/26/2005 | EP1499615A1 Thienyl compounds |
| 01/26/2005 | EP1499613A1 Thioxanthine derivatives as myeloperoxidase inhibitors |
| 01/26/2005 | EP1499611A1 Process for 5- 2(r)- 1(r)- 3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one |
| 01/26/2005 | EP1499605A2 NF-KappaB INHIBITORS |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP1499599A1 Substituted pyrazine derivatives |
| 01/26/2005 | EP1499589A1 Derivatives of n-phenyl(piperidin-2-yl)methyl benzamide, the preparation method thereof and application of same in therapeutics |
| 01/26/2005 | EP1499588A1 Melanocortin receptor ligands |
| 01/26/2005 | EP1499585A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 01/26/2005 | EP1499578A2 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 01/26/2005 | EP1499358A1 Ph-sensitive polymer |
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499345A2 Protein a compositions and methods of use |
| 01/26/2005 | EP1499343A1 A method of modulating cellular activity |
| 01/26/2005 | EP1499336A2 Protease inhibitors |
| 01/26/2005 | EP1499333A2 Methods of treating ileus |
| 01/26/2005 | EP1499331A2 Salt solution for colon cleansing |
| 01/26/2005 | EP1499328A1 Methods of treating necrotizing enterocolitis |
| 01/26/2005 | EP1499322A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 01/26/2005 | EP1499320A1 Novel compounds |
| 01/26/2005 | EP1499316A1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 01/26/2005 | EP1499313A2 Heterocyclic derivatives as opioid receptor modulators |
| 01/26/2005 | EP1499309A1 Prevention and treatment of functional somatic disorders, including stress-related disorders |
| 01/26/2005 | EP1499308A2 Tri-substituted heteroaryls and methods of making and using the same |
| 01/26/2005 | EP1499306A2 Bicyclic amides |
| 01/26/2005 | EP1499305A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 01/26/2005 | EP1499290A1 Warming and nonirritating lubricant compositions |
| 01/26/2005 | EP1499190A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b |
| 01/26/2005 | EP1499186A1 Use of heme oxygenase-1 and products of heme degradation |
| 01/26/2005 | EP1427727B1 Compounds which inhibit the release of inflammatory cytokines |
| 01/26/2005 | EP1379522B1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I |
| 01/26/2005 | EP1301514B1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/26/2005 | EP1296976B1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 01/26/2005 | EP1278749B1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/26/2005 | EP1265942B1 Use of poly(diallylamine) polymers |
| 01/26/2005 | EP1239867B1 Methods for treating and preventing damage to mucosal tissue |
| 01/26/2005 | EP1185524B1 3-heteroarylalkyl substituted gaba analogs |
| 01/26/2005 | EP1084109B1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | EP0828509B1 Composition to improve digestibility and utilisation of nutrients |
| 01/26/2005 | CN1571836A Human antibodies specific for interleukin 15 (IL-15) |
| 01/26/2005 | CN1571794A Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 01/26/2005 | CN1571787A Quinuclidine derivatives processes for preparing them and their uses as M2 and/or M3 muscarinic receptor inhibitors |
| 01/26/2005 | CN1571781A 4-imidazolin-2-one compounds |
| 01/26/2005 | CN1571770A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571674A Use of histamine to treat liver disease |
| 01/26/2005 | CN1571662A Highly compressible ethylcellulose for tableting |
| 01/26/2005 | CN1571659A Granules containing acid-unstable chemical in large amount |
| 01/26/2005 | CN1571654A Oral care substance delivery strip |
| 01/26/2005 | CN1570077A Grifola frondosa mycelia moisture method ultramicro wall break method |
| 01/26/2005 | CN1569895A Yelk antibody specific for preventing pigling diarrhea and its preparing method and application |
| 01/26/2005 | CN1569890A Solid-phase synthesis process of octreotide acetate |
| 01/26/2005 | CN1569849A Rosa banksiae general lactone extract and its preparing process and application |
| 01/26/2005 | CN1569229A IgY product for resisting mouth and upper respiratory tract infection and its application |
| 01/26/2005 | CN1569220A Application of gene recombined anti fungus peptide in the treatment of eumycetes infection |
| 01/26/2005 | CN1569205A Method for preparing and controlling the quality of Chinese medicinal soft capsule |
| 01/26/2005 | CN1569203A 'Wenweishu' soft capsule and its preparation |
| 01/26/2005 | CN1569198A Effervesce tablet of ginseng |
| 01/26/2005 | CN1569191A 'Liuwei Dihuang' oral disintegrating tablet and its preparation |
| 01/26/2005 | CN1569190A Medicine for treating liver cirrhosis |
| 01/26/2005 | CN1569189A Medicine for treating hepatitis A and B |
| 01/26/2005 | CN1569162A Stomach pain easing ointment |
| 01/26/2005 | CN1569143A Gastropathy treating medicine and its preparation |
| 01/26/2005 | CN1569141A Externally applied |
| 01/26/2005 | CN1569132A 'Yangweishu' soft capsule and its preparation |
| 01/26/2005 | CN1569131A 'Wenweishu' soft capsule and its preparation |
| 01/26/2005 | CN1569123A Oral functional Chinese medicine intensified by snake, bee, macroelement and microelement and its preparation |
| 01/26/2005 | CN1569118A Chinese traditional medicinal formulation for protecting alimentary tract mucosa |
| 01/26/2005 | CN1569104A Medicament for treating hepatic fibrosis and hepatic cirrhosis |
| 01/26/2005 | CN1569088A 'Heiguteng' exract, its pharmaceutical composition and its use |
| 01/26/2005 | CN1569073A Liver disease treating medicine |
| 01/26/2005 | CN1569070A Medicine capable of relieving superficial pathologic factors to dissipate heat and soothing liver to normalize stomach function |
| 01/26/2005 | CN1569069A Medicine with functions of nourishing qi, consolidate superficial resistance and suppressing sweating |
| 01/26/2005 | CN1569056A Chinese traditional medicine capable of warming kidney and invigorating yang |